Effects of LSD and 2-bromo LSD on striatal DOPAC levels.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism*; D000818:Animals; D003342:Corpus Striatum / Q000378:metabolism*; D004295:Dihydroxyphenylalanine / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology*; D008297:Male; D010648:Phenylacetates / Q000378:metabolism*; D051381:Rats; D013997:Time Factors
D010648:Phenylacetates; D015102:3,4-Dihydroxyphenylacetic Acid; D004295:Dihydroxyphenylalanine; D008238:Lysergic Acid Diethylamide; D004298:Dopamine